Cav3 CHANNEL BLOCKING AGENT FOR PAIN TREATMENT

摘要

The invention concerns the use of a Cav3, especially Cav3.2, channel blocking agent, ethosuximide in particular, in the treatment or prevention of pain triggered by excess nociception, especially of inflammatory origin. The invention also concerns the use of said agent in the treatment or prevention of inflammatory dysfunctional pain, or in the treatment or prevention of non-inflammatory dysfunctional pain, and the independent or simultaneous use of this agent for anti-inflammatory treatment.